307 related articles for article (PubMed ID: 10418968)
1. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
[TBL] [Abstract][Full Text] [Related]
3. Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1.
Li AP
Chem Biol Interact; 2009 Apr; 179(1):4-8. PubMed ID: 18950609
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
5. Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey and human after cryopreservation.
Martignoni M; Monshouwer M; de Kanter R; Pezzetta D; Moscone A; Grossi P
Toxicol In Vitro; 2004 Feb; 18(1):121-8. PubMed ID: 14630070
[TBL] [Abstract][Full Text] [Related]
6. Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction.
Doshi U; Li AP
J Biomol Screen; 2011 Sep; 16(8):903-9. PubMed ID: 21832258
[TBL] [Abstract][Full Text] [Related]
7. Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors.
Ho MD; Ring N; Amaral K; Doshi U; Li AP
Drug Metab Dispos; 2017 Jun; 45(6):686-691. PubMed ID: 28396528
[TBL] [Abstract][Full Text] [Related]
8. A multi-laboratory evaluation of cryopreserved monkey hepatocyte functions for use in pharmaco-toxicology.
de Sousa G; Nicolas F; Placidi M; Rahmani R; Benicourt M; Vannier B; Lorenzon G; Mertens K; Coecke S; Callaerts A; Rogiers V; Khan S; Roberts P; Skett P; Fautrel A; Chesne C; Guillouzo A
Chem Biol Interact; 1999 Jun; 121(1):77-97. PubMed ID: 10418972
[TBL] [Abstract][Full Text] [Related]
9. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.
Ly VT; Brock B
Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958
[TBL] [Abstract][Full Text] [Related]
10. Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations.
Floby E; Briem S; Terelius Y; Sohlenius-Sternbeck AK
Xenobiotica; 2004; 34(11-12):949-59. PubMed ID: 15801540
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
[TBL] [Abstract][Full Text] [Related]
12. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes.
Easterbrook J; Lu C; Sakai Y; Li AP
Drug Metab Dispos; 2001 Feb; 29(2):141-4. PubMed ID: 11159803
[TBL] [Abstract][Full Text] [Related]
13. A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes).
Li AP; Ho MD; Amaral K; Loretz C
Drug Metab Dispos; 2018 Nov; 46(11):1608-1616. PubMed ID: 29363498
[TBL] [Abstract][Full Text] [Related]
14. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes.
Silva JM; Day SH; Nicoll-Griffith DA
Chem Biol Interact; 1999 Jun; 121(1):49-63. PubMed ID: 10418970
[TBL] [Abstract][Full Text] [Related]
16. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.
Hengstler JG; Utesch D; Steinberg P; Platt KL; Diener B; Ringel M; Swales N; Fischer T; Biefang K; Gerl M; Böttger T; Oesch F
Drug Metab Rev; 2000 Feb; 32(1):81-118. PubMed ID: 10711408
[TBL] [Abstract][Full Text] [Related]
17. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
19. Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes.
Hewitt NJ; Lloyd S; Hayden M; Butler R; Sakai Y; Springer R; Fackett A; Li AP
Chem Biol Interact; 2002 Nov; 142(1-2):73-82. PubMed ID: 12399156
[TBL] [Abstract][Full Text] [Related]
20. Cryopreservation and long-term storage of primary rat hepatocytes: effects on substrate-specific cytochrome P450-dependent activities and unscheduled DNA synthesis.
Shaddock JG; Snawder JE; Casciano DA
Cell Biol Toxicol; 1993; 9(4):345-57. PubMed ID: 8039011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
